GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Cytogen Inc (XKRX:217330) » Definitions » Short-Term Debt

Cytogen (XKRX:217330) Short-Term Debt : ₩754 Mil (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Cytogen Short-Term Debt?

Cytogen's Short-Term Debt for the quarter that ended in Mar. 2024 was ₩754 Mil.

Cytogen's quarterly Short-Term Debt declined from Sep. 2023 (₩9,837 Mil) to Dec. 2023 (₩7,980 Mil) and declined from Dec. 2023 (₩7,980 Mil) to Mar. 2024 (₩754 Mil).

Cytogen's annual Short-Term Debt increased from Dec. 2021 (₩3,280 Mil) to Dec. 2022 (₩25,758 Mil) but then declined from Dec. 2022 (₩25,758 Mil) to Dec. 2023 (₩7,980 Mil).


Cytogen Short-Term Debt Historical Data

The historical data trend for Cytogen's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cytogen Short-Term Debt Chart

Cytogen Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - 3,279.97 25,757.66 7,979.95

Cytogen Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 26,697.71 19,055.50 9,837.19 7,979.95 754.13

Cytogen Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.


Cytogen Short-Term Debt Related Terms

Thank you for viewing the detailed overview of Cytogen's Short-Term Debt provided by GuruFocus.com. Please click on the following links to see related term pages.


Cytogen (XKRX:217330) Business Description

Traded in Other Exchanges
N/A
Address
128, Beobwon-ro, Songpa-gu, A-8 Floor, SK V1 GL Metrocity, Seoul, KOR, 05854
Cytogen Inc is a Korea based company engaged in developing HD Microporous chip using microfluidics and nanotechnology and it captures viable CTCS (circulating tumor cells) from cancer patients blood. The firm operates in two business areas including Liquid Biopsy Applications and Liquid Biopsy Platforms.

Cytogen (XKRX:217330) Headlines

No Headlines